# Cerebrospinal Fluid (CSF) Raltegravir Substudy

> **NCT00718029** · — · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 4 (actual)

## Conditions studied

- HIV Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00718029
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-07
- **Final completion:** 2011-02
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2019-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00718029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00718029, "Cerebrospinal Fluid (CSF) Raltegravir Substudy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00718029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*